HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert K M Choy Selected Research

Infections

1/2024Protocol for the challenge non-typhoidal Salmonella (CHANTS) study: a first-in-human, in-patient, double-blind, randomised, safety and dose-escalation controlled human infection model in the UK.
11/2023The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of abstract-based presentations.
1/2023The Challenge Non-Typhoidal Salmonella (CHANTS) Consortium: Development of a non-typhoidal Salmonella controlled human infection model: Report from a consultation group workshop, 05 July 2022, London, UK.
1/2022Controlled Human Infection Models To Accelerate Vaccine Development.
11/2021A Phase 2a randomized, single-center, double-blind, placebo-controlled study to evaluate the safety and preliminary efficacy of oral iOWH032 against cholera diarrhea in a controlled human infection model.
10/2021Emerging treatment options for cryptosporidiosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert K M Choy Research Topics

Disease

6Infections
01/2024 - 10/2021
5Diarrhea
11/2021 - 08/2011
3Inflammation (Inflammations)
01/2023 - 01/2020
3Cryptosporidiosis
10/2021 - 01/2019
2Cholera
11/2021 - 08/2011
2Growth Disorders
10/2021 - 06/2021
1Gastroenteritis
01/2023
1Premature Birth (Birth, Premature)
10/2022
1Insulin Resistance
10/2022
1Stillbirth
10/2022
1Birth Weight (Birth Weights)
10/2022
1Pregnancy Complications
10/2022
1Communicable Diseases (Infectious Diseases)
01/2022
1Malnutrition (Nutritional Deficiencies)
10/2021
1Parasitic Diseases (Parasitic Disease)
01/2020

Drug/Important Bio-Agent (IBA)

7VaccinesIBA
01/2024 - 06/2021
2Biomarkers (Surrogate Marker)IBA
01/2023 - 10/2022
2Growth Hormone (Somatotropin)IBA
01/2023 - 10/2022
2AcidsIBA
10/2022 - 01/2020
2Chloride Channels (Chloride Channel)IBA
11/2021 - 08/2011
2Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
11/2021 - 08/2011
1Vaccine AdjuvantsIBA
11/2023
1RIX4414 vaccineIBA
01/2023
1Rotavirus VaccinesIBA
01/2023
1Hormones (Hormone)IBA
10/2022
1Immunoglobulins (Immunoglobulin)IBA
10/2022
1Insulin-Like Growth Factor I (IGF-1)IBA
10/2022
1fibroblast growth factor 21IBA
10/2022
1Lipopolysaccharide ReceptorsIBA
10/2022
1C-Reactive ProteinIBA
10/2022
1FlagellinIBA
10/2022
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2022
1Glycoproteins (Glycoprotein)IBA
10/2022
1Fatty Acid-Binding ProteinsIBA
10/2022
1Anti-Bacterial Agents (Antibiotics)IBA
11/2021
1IOWH-032IBA
11/2021
1Clofazimine (Lamprene)FDA Link
10/2021
1Anti-Infective Agents (Microbicides)IBA
06/2021
1Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
01/2021
1herpes simplex virus type 1 glycoprotein gCIBA
01/2020
1Ferritins (Ferritin)IBA
01/2020
1Histidine (L-Histidine)FDA Link
01/2020
1Phosphotransferases (Kinase)IBA
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1Transferrin Receptors (Transferrin Receptor)IBA
01/2020
1Retinol-Binding Proteins (Retinoid Binding Proteins)IBA
01/2020
1ThyroglobulinFDA Link
01/2020
1imidazopyridineIBA
01/2019
1Methionine-tRNA LigaseIBA
01/2019
1nitazoxanide (NTZ)FDA Link
01/2019
1racecadotril (ecadotril)IBA
05/2016
1Charcoal (Charbon)IBA
05/2016
1Neprilysin (Neutral Endopeptidase)IBA
05/2016
1Castor Oil (Oil, Castor)IBA
05/2016

Therapy/Procedure

2Therapeutics
10/2021 - 01/2020
1Fluid Therapy (Oral Rehydration Therapy)
08/2011